ACP-103, a 5-HT2A receptor inverse agonist: Safety, tolerability, and pharmacokinetics in healthy volunteers

被引：0
|
作者：
Vanover, KE
Weiner, DM
Schlienger, N
Thygesen, M
Tolf, B
Hacksell, U
Brann, MR
Davis, RE
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [31] The effects of the hallucinogenic 5-HT2A agonist psilocybin on prepulse inhibition of acoustic startle response in healthy human volunteers
    Quednow, B
    Csomor, PA
    Knappe, B
    Geyer, MA
    Vollenweider, FX
    JOURNAL OF PSYCHOPHYSIOLOGY, 2006, 20 (02) : 120 - 120
  • [32] Agonist-selective internalization of the human 5-HT2A receptor
    Buchborn, T.
    Kahl, E.
    Hoellt, V
    Koch, T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 17 - 17
  • [33] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
    Ramezani, Mahdi
    Shahidi, Siamak
    Afshar, Simin
    Habibi, Parisa
    Hashemi-Firouzi, Nasrin
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
  • [34] Bromocriptine acts as a partial agonist at the human 5-HT2A receptor
    Mitchell, AL
    Phipps, SL
    Grahame-Smith, DG
    Elliott, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U34 - U34
  • [35] Effect of 5-HT2a Receptor Agonist DOI on Epileptiform Activity
    Taskiran, Mehmet
    Tasdemir, Abdulkadir
    Ayyildiz, Mustafa
    Agar, Erdal
    Ayyildiz, Nusret
    ACTA PHYSIOLOGICA, 2015, 215 : 96 - 96
  • [36] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S386 - S386
  • [37] Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356 Following Single and Multiple Oral Administration in Healthy Volunteers
    Tayama, Tomonori
    Ishiuchi, Masatake
    Sugiyama, Kenichiro
    Oka, Yuichi
    Maeda, Hiroshi
    Nagata, Yoshinori
    Hruska, Matthew
    Kagawa, Yoshiyuki
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (08): : 801 - 809
  • [38] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Cselenyi, Z
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 85 - 86
  • [39] Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice
    Buzzi, Belle
    Alsharari, Shakir D.
    Walentiny, David M.
    Damaj, M. Imad
    BEHAVIOURAL BRAIN RESEARCH, 2024, 467
  • [40] Different effects of the 5-HT2A receptor agonist DOI and the 5-HT2A receptor antagonist altanserin on D2 receptor binding in the rat brain
    Nikolaus, S.
    Wittsack, H.
    Beu, M.
    Antke, C.
    Hautzel, H.
    Mori, Y.
    Mamlins, E.
    Antoch, G.
    Mueller, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S635 - S635
12345